Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Runben Biotechnology CoSHSE:603193 -1.79%72 EV-to-FCF is 44.94 as of Jul. 31, 2026, which is 0% below its 10-year median of 45.06. GuruFocus rates SHSE:603193 with a GF Score™ of 72/100 and a GF Value™ of ¥28.24 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,194 Consumer Packaged Goods companies, Runben Biotechnology Co ranks worse than 80.9% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Runben Biotechnology Co's Enterprise Value is ¥7,906 Mil.
Runben Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥176 Mil. Therefore, Runben Biotechnology Co's EV-to-FCF for today is 44.94.
The historical rank and industry rank for Runben Biotechnology Co's EV-to-FCF or its related term are showing as below:
SHSE:603193'
s EV-to-FCF Range Over the Past 10 Years
Min: 21.17 Med: 45.06 Max: 107.04
Current: 43.35
During the past 7 years, the highest EV-to-FCF of Runben Biotechnology Co was 107.04. The lowest was 21.17. And the median was 45.06.
SHSE:603193's EV-to-FCF is ranked worse than 80.9% of 1194
companies
in the Consumer Packaged Goods industry
Industry Median: 16.155
vs SHSE:603193: 43.35
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Runben Biotechnology Co (SHSE:603193) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Runben Biotechnology Co's PE Ratio (TTM) for today is calculated as:
Runben Biotechnology Co's share price for today is ¥21.96.
Runben Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.800.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Runben Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Runben Biotechnology Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Runben Biotechnology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Runben Biotechnology Co's EV-to-FCF falls into.
Runben Biotechnology Co's current Enterprise Value is ¥7,906 Mil.
Runben Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥176 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Runben Biotechnology Co (SHSE:603193) has a EV-to-FCF of 44.94 as of Jul. 31, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Runben Biotechnology Co and its competitors. This is near median its historical median of 45.06. Over the past decade, Runben Biotechnology Co's EV-to-FCF has ranged from 21.17 to 107.04. According to the industry distribution chart, Runben Biotechnology Co ranks #966 out of 1194 companies in the Consumer Packaged Goods industry, placing it in the top 80.9%.
Is Runben Biotechnology Co's EV-to-FCF too high?
Runben Biotechnology Co's current EV-to-FCF of 44.94 is near median its 10-year median of 45.06. Over the past 10 years, this metric has ranged from a low of 21.17 to a high of 107.04. The Consumer Packaged Goods industry median EV-to-FCF is 16.16. Runben Biotechnology Co's value of 44.94 is 178.2% above this industry median. Based on the distribution chart, Runben Biotechnology Co ranks #966 out of 1194 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Runben Biotechnology Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Runben Biotechnology Co's EV-to-FCF compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Runben Biotechnology Co ranks #966 out of 1194 companies for EV-to-FCF. This places Runben Biotechnology Co in the lower half of its industry. The industry median EV-to-FCF is 16.16. Runben Biotechnology Co's value of 44.94 is 178.2% above this benchmark. Historically, Runben Biotechnology Co's own EV-to-FCF has ranged from 21.17 to 107.04 over the past decade. While the company's 10-year median is 45.06 vs. the industry median of 16.16, Runben Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 16.16, based on 1,194 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Runben Biotechnology Co's current EV-to-FCF of 44.94 is 178.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Runben Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 16.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Runben Biotechnology Co's current EV-to-FCF is 44.94, which is near median its own 10-year median of 45.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Runben Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Runben Biotechnology Co (SHSE:603193) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.24, compared to a current price of ¥21.96 — trading 22.2% below its estimated fair value. The current EV-to-FCF is 44.94, which is near median its 10-year median of 45.06 and 178.2% above the Consumer Packaged Goods industry median of 16.16. Runben Biotechnology Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Runben Biotechnology Co (SHSE:603193), the current EV-to-FCF is 44.94 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Runben Biotechnology Co (SHSE:603193) Overvalued in 2026?
Based on GuruFocus' analysis, Runben Biotechnology Co stock appears to be undervalued.
The current stock price of ¥21.96 is trading 22.2% below its estimated GF Value™ of ¥28.24.
GuruFocus considers Runben Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:603193:
EV-to-FCF: 44.94 (near median its 10-year median of 45.06)
GF Value™: ¥28.24 vs. price of ¥21.96 (22.2% below fair value)
Industry Position: 178.2% above the Consumer Packaged Goods median (#966 of 1194)
No single metric tells the full story. See the SHSE:603193 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603193 has been successfully added to your 
